Safety and efficacy of Ovaleap® (recombinant human follicle-stimulating hormone) for up to 3 cycles in infertile women using assisted reproductive technology: a phase 3 open-label follow-up to Main Study

BACKGROUND: Ovaleap® (follitropin alfa), a recombinant human follicle-stimulating hormone intended for use in controlled ovarian stimulation in women undergoing assisted reproductive technologies (ART), showed therapeutic equivalence to Gonal-f® in a multinational, multicenter, randomized, controlle...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Reprod Biol Endocrinol
Main Authors: Strowitzki, Thomas, Kuczynski, Waldemar, Mueller, Arnd, Bias, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4902897/
https://ncbi.nlm.nih.gov/pubmed/27287439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12958-016-0164-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados